市場調査レポート

商品コード

1701408

体外受精の市場規模、シェア、成長分析、製品タイプ別、製品別、タイプ別、機器別、エンドユーザー別、地域別 - 産業予測 2025年～2032年

In Vitro Fertilization Market Size, Share, and Growth Analysis, By Product Type (Fresh Donor, Fresh Non-Donor), By Product (Equipment, Reagents & Media), By Type, By Instrument, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

体外受精市場規模は2023年に268億米ドルと評価され、2024年の290億5,000万米ドルから2032年には553億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.4％で成長する見通しです。

生殖補助医療技術を含む世界の体外受精（IVF）市場は、不妊症の解決策として大きな支持を得ており、外部受精プロセスを通じてカップルの妊娠を可能にしています。ライフスタイルの変化、妊娠の遅れ、様々な健康状態などが原因で不妊率が上昇する中、IVFは自然妊娠の課題に直面している人々に希望を与えています。検査技術の向上、遺伝子検査、胚選択の改良など、絶え間ない技術の進歩が成功率を押し上げ、信頼できる不妊解決策を求めるカップルを魅了しています。体外受精の需要は特に新興国市場で急増しており、認知度とアクセスの向上が市場成長の原動力となっています。治療に伴う精神的・肉体的なハードルはあるもの、新たな技術革新と患者体験の向上が体外受精分野拡大の有望な機会となっています。

市場概要
装置
- 精子分析システム
- イメージングシステム
- 卵子吸引ポンプ
- マイクロマニピュレーターシステム
- インキュベーター
- ガス分析装置
- レーザーシステム
- クライオシステム
- 精子分離装置
- 体外受精キャビネット
- 防振テーブル
- 証人システム
- その他の機器
試薬と培地
- 凍結保存媒体
- 胚培養培地
- 卵子処理培地
- 精子処理培地
アクセサリー

体外受精市場規模：タイプ別& CAGR（2025-2032）

市場概要
従来の体外受精
体外受精と顕微授精
ドナー卵子による体外受精
その他

体外受精市場規模：機器別& CAGR（2025-2032）

市場概要
カルチャーメディア
使い捨てデバイス
資本設備

体外受精市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
不妊治療クリニック
外科センター
病院
調査機関

体外受精市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Ferring Pharmaceuticals（Switzerland）
Merck KGaA（Germany）
Cook Medical（USA）
Vitrolife AB（Sweden）
CooperSurgical, Inc.（USA）
Ovascience, Inc.（USA）
Irvine Scientific（USA）
Genea Limited（Australia）
Origio A/S（Denmark）
Thermo Fisher Scientific Inc.（USA）
Esco Medical ApS（Denmark）
Nidacon International AB（Sweden）
Boston IVF（USA）
Virtus Health（Australia）
Bloom Fertility Centre（India）
Rainbow IVF（India）
IVI RMA Global（Spain）
CHA Healthcare（South Korea）
Reproductive Medicine Associates of New Jersey（RMANJ）（USA）
TSLC Corporation（Japan）

結論と提言

Product Code: SQMIG35H2163

In Vitro Fertilization Market size was valued at USD 26.8 billion in 2023 and is poised to grow from USD 29.05 billion in 2024 to USD 55.39 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global In Vitro Fertilization (IVF) market, encompassing assisted reproductive technologies, has gained significant traction as a solution for infertility, enabling couples to conceive through external fertilization processes. With rising infertility rates attributed to lifestyle changes, late pregnancies, and various health conditions, IVF offers hope to those facing challenges in natural conception. Continuous technological advancements, including enhanced laboratory techniques, genetic testing, and improved embryo selection, have boosted success rates, attracting more couples seeking reliable fertility solutions. The demand for IVF is particularly surging in developing regions, where increased awareness and access are driving market growth. Despite the emotional and physical hurdles associated with the treatment, emerging innovations and improving patient experiences present promising opportunities for expansion in the IVF sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

In Vitro Fertilization Market Segments Analysis

Global In Vitro Fertilization Market is segmented by Product Type, Product, Type, Instrument, End User and region. Based on Product Type, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor and Frozen Non-Donor. Based on Product, the market is segmented into Equipment, Reagents & Media and Accessories. Based on Type, the market is segmented into Conventional IVF, IVF with ICSI, IVF with Donar Eggs and Others. Based on Instrument, the market is segmented into Culture Media, Disposable Devices and Capital Equipment. Based on End User, the market is segmented into Fertility Clinics, Surgical Centers, Hospitals and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market has experienced considerable growth due to remarkable advancements in reproductive technologies observed in 2021. Notably, the implementation of time-lapse imaging systems revolutionized the monitoring process for embryo development by enabling continuous observation. This innovation facilitated better selection of embryos, ultimately resulting in enhanced success rates for IVF procedures. As a result, these technological improvements have encouraged an increasing number of individuals and couples to pursue IVF treatments, thereby driving the overall demand and expansion of the IVF market in recent years.

Restraints in the In Vitro Fertilization Market

The financial burden of In Vitro Fertilization (IVF) treatments has been a considerable constraint, particularly noted in 2021. The high costs associated with medication, laboratory procedures, and the need for several treatment cycles can be overwhelming. This significant expense often renders IVF unattainable for many individuals and couples, especially those lacking sufficient financial means or insurance coverage. As a result, the affordability of these essential reproductive services remains a major barrier, limiting access for those who might benefit from such treatments and hindering their ability to pursue family planning options effectively.

Market Trends of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market is witnessing a notable trend towards the rising demand for genetic testing, particularly techniques like preimplantation genetic testing (PGT). In 2022, the integration of PGT into IVF procedures gained momentum as more couples sought to enhance their chances of successful pregnancies while minimizing the risk of genetic disorders in their future children. This shift is driven by increased awareness of genetic health and advancements in testing technologies, making it a critical factor in reproductive planning. As a result, IVF clinics are increasingly adopting these innovative genetic testing methods, reflecting a broader market trend that favors personalized and health-conscious fertility solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis

Global In Vitro Fertilization Market Size by Product Type & CAGR (2025-2032)

Market Overview
Fresh Donor
Fresh Non-Donor
Frozen Donor
Frozen Non-Donor

Global In Vitro Fertilization Market Size by Product & CAGR (2025-2032)

Market Overview
Equipment
- Sperm Analyzer Systems
- Imaging Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
- Sperm Separation Devices
- IVF Cabinets
- Anti-vibration Tables
- Witness Systems
- Other Equipments
Reagents & Media
- Cryopreservation Media
- Embryo Culture Media
- Ovum Processing Media
- Sperm Processing Media
Accessories

Global In Vitro Fertilization Market Size by Type & CAGR (2025-2032)

Market Overview
Conventional IVF
IVF with ICSI
IVF with Donar Eggs
Others

Global In Vitro Fertilization Market Size by Instrument & CAGR (2025-2032)

Market Overview
Culture Media
Disposable Devices
Capital Equipment

Global In Vitro Fertilization Market Size by End User & CAGR (2025-2032)

Market Overview
Fertility Clinics
Surgical Centers
Hospitals
Research Institutes

Global In Vitro Fertilization Market Size & CAGR (2025-2032)

North America (Product Type, Product, Type, Instrument, End User)
- US
- Canada
Europe (Product Type, Product, Type, Instrument, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Product, Type, Instrument, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Product, Type, Instrument, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Product, Type, Instrument, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ovascience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origio A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Medical ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidacon International AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston IVF (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virtus Health (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bloom Fertility Centre (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rainbow IVF (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IVI RMA Global (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CHA Healthcare (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reproductive Medicine Associates of New Jersey (RMANJ) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TSLC Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments